EnWave Corporation (ENW) - Total Liabilities

Latest as of September 2025: CA$6.55 Million CAD ≈ $4.74 Million USD

Based on the latest financial reports, EnWave Corporation (ENW) has total liabilities worth CA$6.55 Million CAD (≈ $4.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

EnWave Corporation - Total Liabilities Trend (2014–2025)

This chart illustrates how EnWave Corporation's total liabilities have evolved over time, based on quarterly financial data. See EnWave Corporation current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

EnWave Corporation Competitors by Total Liabilities

The table below lists competitors of EnWave Corporation ranked by their total liabilities.

Company Country Total Liabilities
Thermon Group Holdings Inc
NYSE:THR
USA $291.87 Million
Hang Feng Technology Innovation Co., Ltd.
NASDAQ:FOFO
USA $285.10K
Hanwha Investment&Securities Co Ltd Pref
KO:003535
Korea ₩14.19 Trillion
GETS Global Bhd
KLSE:5079
Malaysia RM299.24 Million
Urteste SA
WAR:URT
Poland zł16.75 Million
Lung Hwa Electronics Co Ltd
TW:2424
Taiwan NT$145.44 Million
Invoicery Group AB
ST:FRILAN
Sweden Skr269.63 Million

Liability Composition Analysis (2014–2025)

This chart breaks down EnWave Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EnWave Corporation market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.55 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.35 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EnWave Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EnWave Corporation (2014–2025)

The table below shows the annual total liabilities of EnWave Corporation from 2014 to 2025.

Year Total Liabilities Change
2025-09-30 CA$6.55 Million
≈ $4.74 Million
+75.93%
2024-09-30 CA$3.73 Million
≈ $2.70 Million
-16.63%
2023-09-30 CA$4.47 Million
≈ $3.23 Million
-45.63%
2022-09-30 CA$8.22 Million
≈ $5.95 Million
+7.40%
2021-09-30 CA$7.65 Million
≈ $5.54 Million
-37.84%
2020-09-30 CA$12.31 Million
≈ $8.91 Million
+0.05%
2019-09-30 CA$12.31 Million
≈ $8.90 Million
+134.85%
2018-09-30 CA$5.24 Million
≈ $3.79 Million
+58.21%
2017-09-30 CA$3.31 Million
≈ $2.40 Million
+20.31%
2016-09-30 CA$2.75 Million
≈ $1.99 Million
-24.12%
2015-09-30 CA$3.63 Million
≈ $2.62 Million
-33.99%
2014-09-30 CA$5.50 Million
≈ $3.98 Million
--

About EnWave Corporation

V:ENW Canada Specialty Industrial Machinery
Market Cap
$19.75 Million
CA$27.30 Million CAD
Market Cap Rank
#25181 Global
#981 in Canada
Share Price
CA$0.23
Change (1 day)
-2.13%
52-Week Range
CA$0.23 - CA$0.47
All Time High
CA$0.47
About

EnWave Corporation designs, constructs, markets, and sells vacuum-microwave dehydration machinery for the food, cannabis, and biomaterial industries in Canada, the United States, and internationally. The company licenses radiant energy vacuum (REV) technology that applies microwave energy under vacuum for drying food products, cannabis, biomaterials, and pharmaceutical products and ingredients. I… Read more